A-share biopharmaceutical stocks surged in the short term, with CanSino Biologics hitting the 20% daily limit, and other companies such as Sinocare, Tylenol, Novizan, and Trident Gene following suit.
2026-09-30
A-share biopharmaceutical stocks surged in the short term, with CanSino Biologics hitting the 20% daily limit, and other companies such as Sinocare, Tylenol, Novizan, and Trident Gene following suit.